Rammes G, Rupprecht R, Ferrari U, Zieglgänsberger W, Parsons C G
Max-Planck-Institute of Psychiatry, Kraepelinstrabetae 2-10, D-80804, München, Germany.
Neurosci Lett. 2001 Jun 22;306(1-2):81-4. doi: 10.1016/s0304-3940(01)01872-9.
The type 3 serotonin (5-HT(3)) receptor is a ligand-gated ion channel. In concentration-clamp experiments, we investigated the effects of the uncompetitive N-methyl-D-aspartate (NMDA) receptor antagonists memantine, amantadine and MRZ 2/579 on 5-HT receptors stabley expressed in HEK-293 cells and on native 5-HT(3) receptors in the N1E-115 cell line. All agents antagonized serotonin (10 microM)-induced inward currents with similar potency to that reported for NMDA receptors. This effect was characterized by inducing a pronounced receptor desensitization, and was probably non-competitive and voltage-independent. In contrast, (S)-ketamine was much weaker as an antagonist of 5-HT(3) receptors than NMDA receptors. Similar effects on 5-HT(3) receptors have been reported previously for a variety of anti-depressants and it is possible that the clinical anti-depressant effects reported for both memantine and amantadine are mediated, at least in part, by antagonistic effects at 5-HT(3) receptors.
3型5-羟色胺(5-HT(3))受体是一种配体门控离子通道。在浓度钳实验中,我们研究了非竞争性N-甲基-D-天冬氨酸(NMDA)受体拮抗剂美金刚、金刚烷胺和MRZ 2/579对稳定表达于HEK-293细胞中的5-HT受体以及N1E-115细胞系中的天然5-HT(3)受体的影响。所有药物拮抗5-羟色胺(10微摩尔)诱导的内向电流的效力与报道的NMDA受体相似。这种效应的特征是诱导明显的受体脱敏,可能是非竞争性且与电压无关的。相比之下,(S)-氯胺酮作为5-HT(3)受体拮抗剂的作用比作为NMDA受体拮抗剂的作用弱得多。先前已报道多种抗抑郁药对5-HT(3)受体有类似作用,美金刚和金刚烷胺报道的临床抗抑郁作用可能至少部分是由对5-HT(3)受体的拮抗作用介导的。